Clinical trial
Efficacy and Safety of Yiqi Wenyang Sanhan Formula Combined With Acupoint Application in Patients With Combined Allergic Rhinitis and Asthma Syndrome During Remission and Yang-Deficiency Syndrome: Study Protocol for a Double-Blind Randomized Controlled Trial
NCT07540351 is registered in ClinicalTrials.gov with Beijing Daxing District Hospital of Integrated Chinese and Western Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Yiqi Wenyang Sanhan Formula Combined With Acupoint Application in Patients With Combined Allergic Rhinitis and Asthma Syndrome During Remission and Yang-Deficiency Syndrome: Study Protocol for a Double-Blind Randomized Controlled Trial
- Lead sponsor
- Beijing Daxing District Hospital of Integrated Chinese and Western Medicine
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- December 31, 2027
- Enrollment
- 188 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
allergic rhinitis with asthma